| 发明名称 |
TREATMENT OF KLEBSIELLA PNEUMONIAE WITH LIPOSOMALLY FORMULATED GLUTATHIONE |
| 摘要 |
The composition of the invention, liposomal glutathione, has been recently shown to have utility for having an antibiotic like effect on Klebsiella pneumonia cultures in vitro, and in vivo as demonstrated by efficacy in reducing by large multiples the presence of cultures of Klebsiella in rats in animal tests. Further, because the liposomal glutathione bolsters body defenses as well as appearing to have direct killing action, the propensity to create more and more resistant strains to antibiotic treatment is downgraded. |
| 申请公布号 |
US2015366933(A1) |
申请公布日期 |
2015.12.24 |
| 申请号 |
US201414767985 |
申请日期 |
2014.02.14 |
| 申请人 |
EMORY UNIVERSITY ;YOUR ENERGY SYSTEMS, LLC ;CHILDREN'S HEALTHCARE OF ATLANTA, INC. |
发明人 |
Brown Lou Ann;Guilford Frederick Timothy |
| 分类号 |
A61K38/06;A61K9/127 |
主分类号 |
A61K38/06 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A pharmaceutical composition comprising liposomally formulated reduced glutathione for use in the treatment of a mammalian patient suffering from pneumonia, particularly caused by an infection of Klebsiella pneumoniae. |
| 地址 |
Atlanta GA US |
